Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis.

Saved in:
Bibliographic Details
Title: Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis.
Authors: Kim JL; UBC, Department of Medicine, Vancouver, Canada., Gerrie AS; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Savage KJ; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Villa D; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Scott D; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Craig JW; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada., Farinha P; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada., Skinnider B; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada., Slack G; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada., Connors JM; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Sehn LH; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Venner C; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Freeman CL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2024 Mar; Vol. 65 (3), pp. 346-352. Date of Electronic Publication: 2023 Dec 29.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1029-2403
DOI:10.1080/10428194.2023.2290466